About Us
We have developed a first-in-class therapeutical approach to tackle some of the world's most intractable diseases
We are engineering circular RNAs that target structural elements in the RNA that are crucial for the development of disease and combining them with state-of-the-art delivery techniques. Our technology is based on the research from the Molecular Virology Group of Universitat Pompeu Fabra.
Our multidisciplinary team is committed to bring our technology to the hands of those who need it the most, the patients. Throughout this amazing journey, we also count with the support of our excellent Advisory Board.
Team
Miriam Corredor
PhD, MBI
Chief Executive Officer
Juana Díez
PhD
Chief Scientific Officer
Ivan Dotu
PhD
Vp of Research
Marc Talló
PhD
Principal Researcher